BioNTech to enter into worldwide strategic collaboration with Genentech to develop individualized mRNA cancer therapies

Mainz, Germany, September 21, 2016 - BioNTech AG, a fully integrated…

Chinese FDA Grants MammaTyper® Innovative Product Status for Expedited Approval

Mainz, Germany and Deqing, China, August 19, 2016 — BioNTech…

Study confirms analytical precision of MammaTyper® in molecular breast cancer typing

Mainz, Germany, July 12, 2016:  BioNTech Diagnostics GmbH announces…

Study confirms advantages of the in vitro diagnostic test kit MammaTyper® over immunohistochemistry (IHC)

Mainz, Germany, June 16, 2016: BioNTech Diagnostics GmbH, a subsidiary…

BioNTech Receives Emerging Star of the Year Award at the European Mediscience Awards

Mainz, Germany 14th June 2016 - BioNTech AG, a fully integrated…
Injection Preparation

BioNTech acquires operations of 4SC Discovery division

Planegg-Martinsried, Germany, 29 April 2016 – 4SC AG (4SC,…

BioNTech Announces Update in Immuno-oncology Collaboration with Genmab

Mainz, Germany, 12th January 2016: BioNTech AG, a fully integrated…
JPMorgan

BioNTech to attend and present at 34th Annual JP Morgan Healthcare conference 2016

Mainz, Germany, 16th December 2015: BioNTech AG, a fully integrated…

BioNTech and Shuwen announce partnership to commercialize MammaTyper® in China

Mainz, Germany and Deqing, China, December 3, 2015 – BioNTech…

Sanofi and BioNTech Announce Cancer Immunotherapy Collaboration and License Agreement

Paris, France and Mainz, Germany – November 3, 2015 – Sanofi…

November 2015: HIV scientists launch 23 million euro project to develop vaccine

A new 23 million euro initiative to accelerate the search for…

June 2015 - Cancer Research Consortium “IMMUNO-TRANSPORTER” funded by Federal Ministry of Education and Research

Mainz, Heidelberg, Stuttgart June 2015 – The newly established…

June 2015 – Siemens and BioNTech cooperate on production of personalized cancer vaccines

Strategic collaboration for the GMP production of personalized…